|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.54 USD | -0.42% |
|
-3.18% | -27.56% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Other Pharmaceuticals | -0.42% | -3.18% | -27.56% | +12.44% | +48.08% | 1.09B |  |  | |
- Stock Market
- Stocks
- COLL Stock
- Charts Collegium Pharmaceutical, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
